Vanguard Capital Management
ROIV icon

Vanguard Capital Management’s Roivant Sciences ROIV Stock Holding History

Vanguard Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$783M Buy
22,123,198
+1,442,626
+7% +$42.6M 0.02% 558
2026
Q1 		$573M Buy
+20,680,572
New +$531M 0.01% 620

Other funds holding ROIV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Vanguard Capital Management's ROIV Position: Q2 2026 in Review

Vanguard Capital Management increased its Roivant Sciences (ROIV) stake by 7% in Q2 2026, buying an estimated $42.6M and bringing the position to 22,123,198 shares worth $783M. The position accounts for 0.02% of the portfolio, ranked #558.

Vanguard Capital Management first reported a position in ROIV in Q1 2026 and has held it in 2 quarters since. 464 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Vanguard Capital Management held 22,123,198 shares of Roivant Sciences worth $783M as of Q2 2026.
  • Vanguard Capital Management bought 1,442,626 Roivant Sciences shares in Q2 2026, an estimated $42.6M.
  • Roivant Sciences made up 0.02% of Vanguard Capital Management's portfolio in Q2 2026, its #558 holding.
  • Vanguard Capital Management first reported a position in Roivant Sciences in Q1 2026 and has held it in 2 quarters since.
  • 464 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.